Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Acacia Pharma discloses phase IIa data on APD-209

Dec. 12, 2011

Amgen describes new ALK tyrosine kinase receptor inhibitors

Dec. 12, 2011

Janssen Biotech and Pharmacyclics enter agreement for anticancer drug

Dec. 12, 2011

New serine/threonine-protein kinase Chk1 inhibitor shows antitumor in vivo

Dec. 12, 2011

Genosco and Oscotec disclose promising therapeutics for acute myeloid leukemia

Dec. 12, 2011

Ono Pharmaceutical announces new launch in Japan

Dec. 9, 2011

Cyclacel Pharmaceuticals reports interim data from sapacitabine trials

Dec. 9, 2011

TetraLogic Pharmaceuticals begins new phase I/II TL-32711 trial

Dec. 9, 2011

New inhibitors of fatty acid synthase presented

Dec. 9, 2011

Studies provide insight into TL-32711 activity and dosing

Dec. 9, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...